ADMA Biologics, Inc (NASDAQ:ADMA) Projects Continued Margin Expansion Amid Legal Headwinds
![]() |
Operational performance shows strong margin expansion and cash generation, while recent legal filings create event-driven volatility. Near-term price action should reflect that split between fundamentals and headline risk. |









